Skip to main content
. Author manuscript; available in PMC: 2022 Dec 1.
Published in final edited form as: Thorax. 2021 Jul 16;76(12):1186–1192. doi: 10.1136/thoraxjnl-2020-215918

Table 2:

Shorter PBL-TL is a risk factor for ILD in UCSF SSc patients in a multivariable logistic regression model

OR 95%CI P-value
Age 0.99 0.97–1.02 0.60
Male gender 0.42 0.12–1.21 0.12
BMI 1.05 0.98–1.13 0.19
Hispanic ethnicity 1.97 0.73–5.78 0.20
Smoking history 1.16 0.80–1.68 0.43
Anti-topoisomerase antibody 4.61 2.05–11.23 <0.001
SSc subtype, diffuse 1.49 0.74–3.08 0.27
TL (per 1kb decrease) 2.11 1.25–3.70 0.006

PBL, peripheral blood leukocyte; TL, telomere length; ILD: interstitial lung disease; UCSF, University of California San Francisco; SSc, systemic sclerosis; OR, odds ratio; CI, confidence interval; BMI, body mass index.